JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 26, 2007; DOI: 10.1124/jpet.106.112607


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.112607v1
321/3/1003    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodd, Z. A.
Right arrow Articles by McBride, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodd, Z. A.
Right arrow Articles by McBride, W. J.


Received for publication August 22, 2006.
Revised February 22, 2007.
Accepted for publication February 22, 2007.

The Reinforcing Actions of a Serotonin-3 Receptor Agonist within the Ventral Tegmental Area: Evidence for Subregional and Genetic Differences, and Involvement of Dopamine Neurons

Zachary A. Rodd 1*, Victoria E. Gryszowka 1, Jamie E. Toalston 2, Scott M. Oster 2, Dong Ji 1, Richard L. Bell 1, William J. McBride 1

1 Indiana University: School of Medicine 2 Indiana University-Purdue University at Indianapolis

* Address correspondence to: E-mail: zrodd{at}iupui.edu

Abstract

Rationale: Studies from our laboratory indicated that local perfusion of the ventral tegmental area (VTA) with a serotonin-3 (5-HT3) receptor agonist increased dopamine (DA) neuronal activity, and that the self-infusion of ethanol (EtOH) and cocaine into the posterior VTA could be inhibited with co-administration of a 5-HT3 receptor antagonist. Objectives: The study tested the hypothesis that activating 5-HT3 receptors within the VTA produces reinforcing effects. The study also examined whether there were differences between Wistar rats and a line of rats selectively bred for high alcohol consumption with regard to the self-infusion of a 5-HT3 receptor agonist within the VTA. Methods: Adult female alcohol-preferring (P) and Wistar rats were allowed to self-infuse the 5-HT3 receptor agonist, 1-(m-chlorophenyl)-biguanide (CPBG), into the posterior or anterior VTA. Additionally, experiments examined the effects of co-infusion of the 5-HT3 antagonist ICS 205,930 (ICS), and the DA D2,3 agonist quinpirole on the self-infusion of CPBG. Results: Both Wistar and P rats readily self-administered CPBG into the posterior, but not anterior, VTA. P rats self-infused lower concentrations of CPBG (0.10 µM) than did Wistar rats (1.0 µM). Co-infusion of either ICS or quinpirole reduced CPBG self-infusion into the posterior VTA. Conclusions: The results of this study suggest that activation of 5-HT3 receptors within the posterior VTA produces reinforcing effects, and that these reinforcing effects are mediated through activation of DA neurons. Additionally, the data suggest that selective breeding for alcohol-preference results in the posterior VTA being more sensitive to the reinforcing effects of CPBG.


Key words: alcohol-preferring (P) rats, reinforcement, reward, self-administration, serotonin-3 receptors, ventral tegemental area





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.